LifeScan

LifeScan is a global diabetes-care company best known for its OneTouch brand of blood-glucose monitoring systems, used by more than 20 million people. Founded in 1981 and acquired by Johnson & Johnson in 1986, it operated for decades as J&J's diabetes-monitoring business before being divested to Platinum Equity for $2.1 billion in 2018. After a 2025 restructuring it emerged under new ownership, remaining headquartered in Malvern as it pivots toward next-generation continuous glucose monitoring.